<DOC>
	<DOCNO>NCT02245620</DOCNO>
	<brief_summary>This study Phase 2 , randomize , double-blind , placebo-controlled study , enrol 40 elderly subject previous evidence mitochondrial dysfunction evaluate whether administration MTP-131 change either hand skeletal muscle energetics muscle performance age-related skeletal muscle mitochondrial dysfunction .</brief_summary>
	<brief_title>A Phase 2 Study Evaluate Impact MTP-131 ( Bendavia™ ) Skeletal Muscle Function Elderly</brief_title>
	<detailed_description />
	<criteria>1 . Are male female adult age ≥60 ≤85 year 2 . Female subject must postmenopausal 3 . Have vivo 31P MRS ( Magnetic Resonance Spectroscopy ) OPS ( Optical Spectra Scan ) determine ATPmax ( Maximal ATP synthetic rate ) &lt; 0.70 mM/sec 4 . Have vivo 31P MRS ( Magnetic Resonance Spectroscopy ) OPS ( Optical Spectra Scan ) determine P/O ( Phosphate/Oxygen ratio ) &lt; 1.9 5 . Are ambulatory able perform activity daily live without assistance 1 . Have significant disease ( ) condition ( ) , opinion investigator , may put subject risk his/her participation study may influence either result study subject 's ability participate study . 2 . Have hospitalize within 3 month prior screen major atherosclerotic event ( e.g . myocardial infarction , targetvessel revascularization , coronary bypass surgery stroke ) major medical condition ( deem primary investigator ) 3 . Have metal implant remove body opinion investigator contraindication undergo MRS procedure protocolrelated procedure ) 4 . Have implant cardiac pacemaker implant cardiac device 5 . Have chronic , uncontrolled hypertension judge Investigator 6 . Have BMI &lt; 16 &gt; 32 kg/m2 7 . Have creatinine clearance &lt; 45 mL/min calculate CockcroftGault equation 8 . Subject 's right hand history mobility impairment , fracture , arthritis , hand surgery , muscle disease injury may interfere study procedure Other protocoldefined inclusion/exclusion criterion may apply .</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Skeletal muscle dysfunction , MTP-131 , Bendavia™</keyword>
	<keyword>elamipretide</keyword>
</DOC>